Internal Medicine, Critical Care Medicine · Charleston, SC
NPI
1427155217
Since 2006
Specialty
Internal Medicine, Critical Care Medicine
Code 207RC0200X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
171 Ashley Ave
Charleston, SC, 29425
Phone (843) 792-1414
Groups this clinician bills Medicare through
Medicare paid, 2024
$29K
279 services
Medicare patients, 2024
153
Average age 69
Drug cost, 2024
$1.2M
459 prescriptions
Company payments, 2025
$40K
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Charlton B Strange was code 99291 (critical care e&m), 123 times for 60 patients. In total Charlton B Strange billed 279 services in 21 codes, and Medicare paid $29K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-06-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99291 Critical Care E&M | Facility | 123 | 60 | $157.23 | $19K |
| 99214 Office E&M - Established | Facility | 44 | 35 | $65.42 | $2,879 |
| 99233 Hospital E&M - Subsequent | Facility | 24 | 19 | $87.46 | $2,099 |
| 94618 Pulmonary Function Testing | Facility | 12 | 12 | $16.52 | $198 |
By year: 2022 $38K for 323 services; 2023 $24K for 218 services; 2024 $29K for 279 services.
Medicare prescription drug claims, 2024
In 2024, the drug Charlton B Strange prescribed most often to Medicare patients was Prednisone, with 51 prescriptions and refills. In total Charlton B Strange wrote 459 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 51 | 92 | 19 | $327 |
| Zemaira Alpha-1-Proteinase Inhibitor | 37 | 37 | Under 11 | $456K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 26 | 48 | Under 11 | $1,231 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 22 | 46 | Under 11 | $26K |
| Spiriva Respimat Tiotropium Bromide | 21 | 35 | Under 11 | $19K |
| Prolastin C Alpha-1-Proteinase Inhibitor | 21 | 21 | Under 11 | $193K |
| Aralast Np Alpha-1-Proteinase Inhibitor | 17 | 24 | Under 11 | $340K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 16 | 24 | Under 11 | $11K |
| Spiriva Handihaler Tiotropium Bromide | 15 | 17 | Under 11 | $8,431 |
| Breo Ellipta Fluticasone/Vilanterol | 14 | 16 | Under 11 | $6,204 |
| Combivent Respimat Ipratropium/Albuterol Sulfate | 14 | 18 | Under 11 | $7,931 |
| Symbicort Budesonide/Formoterol Fumarate | 13 | 23 | Under 11 | $4,922 |
| Azithromycin Generic | 12 | 16 | Under 11 | $127 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 11 | 11 | Under 11 | $66.07 |
| Ambrisentan Generic | 11 | 11 | Under 11 | $53K |
Brand drugs: 267 claims; generic drugs: 192 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Charlton B Strange $40K ($40K in general payments such as food, travel and fees) from 6 companies. The largest payer was CSL Behring with $22K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.